GuiZhou SanLi Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd Dividend Yield on January 27, 2025: 0.80%

GuiZhou SanLi Pharmaceutical Co.,Ltd Dividend Yield is 0.80% on January 27, 2025, a 31.95% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week high Dividend Yield is 0.92% on August 23, 2024, which is 15.93% above the current Dividend Yield.
GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week low Dividend Yield is 0.57% on March 18, 2024, which is -28.23% below the current Dividend Yield.
GuiZhou SanLi Pharmaceutical Co.,Ltd average Dividend Yield for the last 52 weeks is 0.74%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Shanghai Stock Exchange: 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd

CEO	Mr. Hai Zhang
IPO Date	April 28, 2020
Location	China
Headquarters	Xiayun Industrial Park
Employees	2,282
Sector	Health Care
Industries Pharmaceuticals

Description

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years